S&P Lowers Valeant Credit Rating After Delayed SEC Filing
Standard & Poor's Ratings Services lowered the credit rating of Valeant Pharmaceuticals International Inc. Thursday, citing a default on $1 billion in notes triggered by the company's late filing with the...To view the full article, register now.
Already a subscriber? Click here to view full article